Wednesday, August 12, 2009

Pacific Biosciences Gets $68M

Menlo Park-based Pacific Biosciences, a developer of DNA sequencing technology, reported Wednesday that it has raised $68M in funding. The funding included investments from Monsanto and the Wellcome Trust, as well as Sutter Hill Ventures and its prior investors. Prior investors in the company include Deerfield Management, Intel Capital , Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures, Maverick Capital, AllianceBernstein, DAG Ventures, Teachers’ Private Capital, and Blackstone Cleantech Venture Partners. Pacific Biosciences said it has now raised $188M in funding since last summer. More information »